Our pathologists and researchers are skilled at diagnosing common and rare ovarian cancers, including:
- Epithelial: This is the most common type of ovarian cancer, which starts in the epithelial tissue, the lining on the outside of the ovary or in the fallopian tube. Epithelial ovarian cancer also includes primary peritoneal cancer and fallopian tube cancer.
This type of ovarian cancer is divided into serous (high grade and low grade), mucinous, endometrioid (high grade and low grade), clear cell, transitional, and undifferentiated types. Ovarian carcinosarcoma is another rare type of ovarian cancer
that we treat.
- Germ cell: Germ cell tumors begin in the egg-producing cells. The main subtypes are teratoma, dysgerminoma, endodermal sinus tumor, and choriocarcinoma.
- Sex cord stromal: These rare tumors grow in the connective tissue that holds the ovary together and makes estrogen and progesterone. Sub-types include granulosa, granulosa-theca, and Sertoli-Leydig cell tumors.
If you would like a second opinion...
Our diagnostic team provides second opinions, including for challenging or difficult cases. We are happy to consult with you, your primary care physician, or other specialists.
You may want to consider a second opinion:
- To confirm your diagnosis
- For an evaluation of an uncommon presentation
- For details on the type and stage of cancer
- To better understand your treatment options
- To learn if you are eligible for clinical trials
Phone: 877-442-DFCI or 877-442-3324
Online: Complete the
Appointment Request Form
If you cannot travel to Boston in person, you can take advantage of our
Online Second Opinion service.
Tests to diagnose ovarian cancer
After our doctors carefully review your medical history and your familial risk of developing ovarian cancer, and complete a pelvic exam, they will conduct a combination of biopsies and imaging tests. The results from these tests are reviewed regularly
by a dedicated gynecology team of surgeons, medical oncologists, and radiation oncologists at a weekly tumor board meeting. This team will determine the best course of treatment specific to your type of ovarian cancer.
There is no standard screening test to identify ovarian cancer. Diagnosis of ovarian cancer begins with a pelvic exam with your doctor, which can be helpful in identifying a mass on either side of the uterus.
Recommended tests to determine the presence of ovarian cancer
- Transvaginal ultrasound: a procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs, such as the vagina, uterus,
fallopian tubes, and bladder. The wave echoes form a picture of body tissues called a sonogram.
- Blood test: a test to measure a substance in the blood called CA-125 (a tumor marker that is often found to be elevated in the blood of women with ovarian cancer). This test is used to monitor the progress of treatment.
- CT Scan and Surgery: When the presence of ovarian cancer is detected, a CT scan or another radiologic procedure is performed to determine the extent of the disease. If the disease appears resectable (able to be removed through surgery), surgery is performed to make a definitive diagnosis and remove the tumor. If the disease does not appear to be resectable, a biopsy is performed to make a definitive diagnosis and determine the course of treatment.
Inherited gene mutations
Up to 20 percent of ovarian, fallopian tube, and peritoneal cancers are caused by inherited gene mutations, such as the BRCA1 and BRCA2 genes and Lynch syndrome genes. Genetic testing can detect these mutated genes for family members with
a high risk of ovarian cancer.
Detecting a mutated gene does not mean that you will develop cancer, or that cancer is currently present. Learning whether or not you carry a genetic mutation may influence how, how often, and when you and your family begin cancer screenings. In some cases, in patients who do not wish to have more children, removing the fallopian tubes and ovaries will significantly reduce the risk of eventually developing ovarian or fallopian tube cancer. In these cases, the tubes and ovaries are carefully examined by pathologists who are experts in detecting early cancers.
If you or your doctor thinks you are at high risk of developing ovarian cancer, the
Cancer Genetics and Prevention Program at Dana-Farber can create a personalized program to accurately estimate your risk and work with you — together with your physicians and nurse practitioners — to
lower your risk as much as possible.
Tests to determine the stage of ovarian cancer
If ovarian cancer is found after examining ovarian tissue samples, further tests are done to see if the cancer cells have spread within the ovaries or to other parts of the body. The process used to find out if and how far the cancer has spread beyond
the uterus is called staging. Tests and procedures that may be used in the staging process include CT scan, PET scan, MRI (Magnetic Resonance Imaging), and surgical procedures.
Stages of ovarian cancer
Information from exams and diagnostic tests is used to determine the extent of the tumor, and whether or not the cancer has spread to the lymph nodes or other tissues. The staging of ovarian cancer is the most important factor in determining a treatment
The stages of epithelial ovarian cancer are:
- Stage I indicates cancer in one or both ovaries. Cancer cells may be found on the surface of the ovaries, inside the ovaries, or in fluid surrounding the abdomen.
- Stage II means that cancer is found in one or both ovaries, as well as other areas in the pelvis. Cancer cells can be found in the fallopian tubes, uterus, or other tissues in the pelvis, as well as the tissue or fluid surrounding the abdomen.
- Stage III signifies cancer has spread beyond the ovaries and pelvis, to the abdomen (abdominal wall or small intestines) or nearby lymph nodes. Cancer cells may also be found on the outside of the liver.
- Stage IV indicates that cancer has spread beyond the ovaries, abdomen, and pelvis to other parts of the body, such as the lungs, the liver, or other tissues. Cancer cells found in the fluid around the lungs are also considered stage IV ovarian